MedPath

Pre-Operative Sterilization Study of Levofloxacin Ophthalmic Solution 1.5%

Not Applicable
Conditions
Diseases necessary for intraocular Surgery
Registration Number
JPRN-UMIN000007622
Lead Sponsor
Miyata eye Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with history of hypersensitivity or severe adverse effects on newquinolone antibiotics 2.Patients suspecting bacterium, fungus or virus infection 3.Patients administered antibiotics or immunosuppressants within 3 months prior to the study 4.Patients hospitalized other than ocular surgeries 5.Patients with uncontrollable underlying disorders or complications 6.Pregnant or breast-feeding women 7.Patients wearing contact lenses during the study 8.Patients having history of ocular surgery within 3 months prior to the study on the study eye 9. Patients whom investigators estimate are not eligible

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pre-Operative bacterial eradication rate of Levofloxacin Ophthalmic Solution 1.5%
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath